IL6 and hepatocellular carcinoma: Interestingly, IL-6 knockdown in cancer associated fibroblasts (CAF) increased IFN-γ on CD8-postive T cells and IL-6 blockade could reverse anti-PD-L1 resistance in an HCC mouse model [48].